Table 2.
Comparison of clinical parameters.
| Characteristics | Resveratrol Group 35 | Placebo Group 35 | After RV→Placebo | ||||
|---|---|---|---|---|---|---|---|
| Before | After | p | Before | After | p | p | |
| Urea | 51.80 ± 6.10 | 48.20 ± 6.40 | 0.019 | 51.40 ± 5.90 | 50.20 ± 6.10 | N.S | N.S |
| Ammonia | 66.20 ± 7.80 | 41.40 ± 6.80 | <0.001 | 62.80 ± 7.40 | 59.70 ± 6.70 | N.S | <0.001 |
| AST | 87.80 ± 10.70 | 40.40 ± 9.80 | <0.001 | 80.40 ± 9.80 | 75.20 ± 8.70 | 0.022 | <0.001 |
| ALT | 96.40 ± 11.80 | 78.40 ± 8.70 | <0.001 | 91.70 ± 10.20 | 84.20 ± 10.20 | 0.003 | 0.013 |
| γ-GT | 46.10 ± 6.70 | 40.40 ± 6.40 | <0.001 | 40.80 ± 6.40 | 40.50 ± 6.10 | N.S | N.S |
| Prothrombine time | 15.40 ± 1.80 | 15.00 ± 1.20 | N.S | 15.50 ± 1.70 | 15.10 ± 1.60 | N.S | N.S |
| Bilirubin | 2.00 ± 0.40 | 2.10 ± 0.50 | N.S | 2.10 ± 0.40 | 2.00 ± 0.50 | N.S | N.S |
| Albumin | 3.50 ± 0.50 | 3.70 ± 0.80 | N.S | 3.60 ± 0.50 | 3.60 ± 0.70 | N.S | N.S |
AST = Aspartate aminotranferase; ALT = alanine aminotransferase; γ-GT = gamma-glutamyl transpeptidase; RV = Resveratrol; N.S = not significant.